Regístrese
Buscar en
Actas Urológicas Españolas (English Edition)
Toda la web
Inicio Actas Urológicas Españolas (English Edition) Most Often Read Most Often Read
Journal Information

Most Often Read

6
Current status of young urologists and residents’ activity and academic training in Spain. National survey results
M. Rodríguez Socarrás, M. Ciappara, M. García Sanz, L. Pesquera, D.M. Carrión, L. Tortolero, J. Palou Redorta, J.M. Cózar-Olmo, M. Esteban Fuertes, J. Gómez Rivas
Actas Urol Esp.2019;43:169-75
6
6
Current status of radiological protection in endourological procedures in Spain
D. Pérez-Fentes, M. Pombar-Cameán, J.L. Álvarez-Ossorio Fernández
Actas Urol Esp.2019;43:205-11
6
6
Urethral reconstruction in patients previously treated with Memokath™ urethral endoprosthesis
J.C. Angulo, J. Pankaj, I. Arance, S. Kulkarni
Actas Urol Esp 2019;43:26-31
6
5
Objective assessment of early urinary continence by analysis and visualisation of intraoperative variables of radical robotic prostatectomies with a video editor
J.C. Bautista Vidal, E. García Galisteo, J. Barón López, N. Sánchez Martínez, D. Hernández Alcaraz, P. Morales Jiménez, R. Vozmediano Chicharro
Actas Urol Esp.2019;43:99-105
5
4
Incidence of second tumours in high risk prostate cancer patients according to the primary treatment applied
J. Caño-Velasco, F. Herranz-Amo, G. Barbas-Bernardos, L. Polanco-Pujol, E. Lledó-García, C. Hernández-Fernández
Actas Urol Esp 2019;43:18-25
4
4
Cognitive function assessment in elderly patients with overactive bladder treated with transdermal oxybutynin
C. Müller-Arteaga, J.E. Batista-Miranda, C. Zubiaur Libano, R. El Khoury Moreno, G. Morales Solchaga, J. Casas Nebra, M. Leva Vallejo, O. Gonzalez Garcia, C. Errando-Smet, S. Arlandis-Guzman
Actas Urol Esp.2019;43:143-50
4
4
Effectiveness of the “cognitive” biopsy in the diagnosis of prostate cancer in patients with a previous negative biopsy
G. Barbas Bernardos, F. Herranz Amo, E. de Miguel Campos, A. Luis Cardo, A. Herranz Arriero, J. Caño Velasco, M.J. Cancho Gil, J. Jara Rascón, J. Mayor de Castro, C. Hernández Fernández
Actas Urol Esp 2019;43:12-7
4
4
Sarcomatoid urothelial bladder carcinoma in adults: Histology, symptomatology, treatments and survival
X.A. Sabaté Arroyo, H. Rodrigo Lara, P. Carrillo García, J. Brugarolas Rosselló, P. Pizá Reus
Actas Urol Esp.2019;43:106-10
4
3
A new approach to laparoscopic implantation of artificial urinary sphincter: Vesicovaginal approach to the bladder neck
M. Ruiz-Hernández, L. López-Fando, J.M. Gómez de Vicente, M.A. Jiménez-Cidre, M.D. Sánchez-Gallego, J. Lorca-Álvaro, D. Díaz-Pérez, F.J. Burgos-Revilla
Actas Urol Esp 2019;43:44-50
3
3
Usefulness of PET/CT 18-FDG for the diagnosis and follow-up of urological, urothelial and kidney tumours
C. González-Ruiz de León, J. García-Rodríguez, N. Pérez-Castro, C. Vigil-Díaz, M.L. Pérez-Haro, J.M. Fernández-Gómez
Actas Urol Esp 2019;43:32-8
3
3
Three-year interim results of overall and progression-free survival in a cohort of patients with prostate cancer (GESCAP group)
J.M. Cózar, B. Miñana, F. Gómez-Veiga, A. Rodríguez-Antolín
Actas Urol Esp 2019;43:4-11
3
3
Endourological treatment of symptomatic ureteral stump posnephrectomy
B. Fernández-Bautista, A. Parente Hernández, R. Ortiz Rodríguez, L. Burgos Lucena, J.M. Angulo Madero
Actas Urol Esp 2019;43:39-43
3
3
Influence of laparoscopic access in cancer-specific mortality of patients with pTa-2pN0R0 bladder cancer treated with radical cistectomy
D. Subirá-Ríos, F. Herranz-Amo, T. Renedo-Villar, M. Moralejo-Gárate, G. del Pozo-Jiménez, G. Bueno-Chomón, E. Rodríguez-Fernández, I. Moncada-Iribarren, C. Hernández-Fernández
Actas Urol Esp.2019;43:241-7
3
2
The role of STAT3 protein as a prognostic factor in the clear cell renal carcinoma. Systematic review
D. Lorente, E. Trilla, A. Meseguer, J. Arevalo, S. Nemours, J. Planas, J. Placer, A. Celma, C. Salvador, L. Regis, I. Schwartzmann, J. Morote
Actas Urol Esp.2019;43:118-23
2
2
Scientific social media, a new way to expand knowledge. What do urologists need to know?
J. Gómez Rivas, D.M. Carrion, L. Tortolero, D. Veneziano, F. Esperto, F. Greco, G. Cacciamani, A. Dourado Meneses, Z. Okhunov, M. Rodriguez Socarrás
Actas Urol Esp.2019;43:269-76
2
2
5-alpha reductase inhibitors: New evidences on benefits and harms beyond benign prostatic hyperplasia
A. Alcántara Montero, C. Müller-Arteaga
Actas Urol Esp 2019;43:52-3
2
2
Diagnosis of metastases in castration-resistant prostate cancer patients: Decision algorithm in imaging tests
A. Juárez-Soto, J.M. Garín-Ferreira, A. Rodríguez-Fernández, J.L. Tirado-Hospital, M.T. González-Serrano, J. Moreno-Jiménez, R. Medina-López, V. Baena-González
Actas Urol Esp.2019;43:55-61
2
2
Bladder pain syndrome: Prevalence and routine clinical practice in women attending functional urology and urodynamics units in Spain
G. Morales-Solchaga, C. Zubiaur-Libano, L. Peri-Cusí, J.M. Adot-Zurbano, S. Arlandis-Guzmán, A. Franco-de Castro, C. Castillejo
Actas Urol Esp.2019;43:62-70
2
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.